Skip to main content

Retension Pharmaceuticals, Inc.

RTSN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002002988

In the last 90 days, Retension Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Politicians who traded RTSN

No member of Congress has reported a trade in Retension Pharmaceuticals, Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.